Skip to content
Research Article Open access CC BY 4.0

The Role of SGLT 2 Inhibitor in the Therapy of Obesity

Giovanno Sebastian Yogie, Darren Gosal, Yohanes Firmansyah, Alexander Halim Santoso

Asian Journal of Research and Reports in Endocrinology · pp. 104–114 · Published 9 Jul 2023

Abstract

Obesity is an abnormal or excessive fat accumulation that presents a risk to health, including hypertension, stroke, kidney disease, atherosclerosis, type 2 diabetes mellitus, heart disease, and sleep apnea. Obesity can be caused by various aetiology, such as genetics, lifestyle, psychology, treatment, and more. Treatment of obesity is needed to prevent these further complications. According to various studies, SGLT 2 inhibitor has shown effectiveness in losing weight. This review article aims to describe the effectiveness and safety of SGLT 2 inhibitors in the treatment of obesity. It is expected SGLT 2 inhibitor can be considered in the administration of therapy in patients with obesity.

Obesity SGLT 2 inhibitor weight loss

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.